Novel Treatments & Drugs

Gavo-Cel Moving to Phase II Trial for Mesothelioma

A study looking at T-cell therapy for mesothelioma is going to phase II of the clinical trial process. Researchers are trying to find out how effective the treatment is when combined with an approved immunotherapy combination. Researchers are looking at the relationship between gavocabtagene autoleucel (gavo-cel) with the combination of[…]

Read More »

Pleural Mesothelioma and Brain Metastasis

When people are diagnosed with mesothelioma, it is common for the disease to spread. This occurs in around 60 percent of people, but it does not usually spread to the brain. Researchers in Great Britain believe doctors should be focusing on cerebral metastasis in mesothelioma patients in addition to other[…]

Read More »

Enzyme and Chemotherapy Combination for Mesothelioma

Pleural mesothelioma sufferers could improve their survival by as much as 30 percent when treated with the latest cancer enzyme and chemotherapy. In a recent study known as ATOMIC Meso, ADI-PEG 20 showed effectiveness when used for sarcomatoid and biphasic mesothelioma, the two most resistive to treatment. The enzyme is[…]

Read More »

STAR-101 Could Make CAR T-Cell Therapy More Effective for Mesothelioma Patients

Early next year, a new clinical trial will be conducted to test an immunotherapy treatment that has a new and unique delivery system. The study will be conducted at the University of Pennsylvania. The Food and Drug Administration gave orphan drug status to SynKIR-110, a CAR T-cell therapy utilized for[…]

Read More »

A Protein Could Make Chemotherapy More Effective on Mesothelioma

Mesothelioma is a rare cancer with a poor life expectancy. People diagnosed with pleural mesothelioma usually live for four to 18 months after diagnosis. The poor survival is a result of the aggressive nature of the cancer and that it is usually diagnosed at a late stage when it is[…]

Read More »

Allocetra and Cisplatin Combination for Mesothelioma

A new immunotherapy treatment is showing promising results against mesothelioma. The therapy consists of a combination of two drugs: one drug that reprograms macrophages and the other is the chemotherapy cisplatin. Mesothelioma is a cancer that does not respond well to treatment. The best option for patients is a combination[…]

Read More »

Drug Factories Treatment Being Tested for Mesothelioma

Researchers have found a treatment that can eradicate advanced stage mesothelioma tumors within a few days. The research is being done at Rice University and Baylor College of Medicine. The treatment utilizes implants known as “drug factories” and a checkpoint inhibitor drug. Mesothelioma is a tough to treat cancer of[…]

Read More »

Keytruda as a Second Line Treatment for Mesothelioma

A new second line treatment has been developed for pleural mesothelioma. The treatment was created at the Netherlands Cancer Institute in Amsterdam. Research was done as a single-arm, open-label clinical trial combining pembrolizumab (Keytruda) and lenvatinib. The results were presented at the IASCL 2022 World Conference on Lung Cancer in[…]

Read More »

A New Blood Test That Can Diagnose Mesothelioma Has Been Developed

A blood test could make diagnosing mesothelioma faster, leading to doctors catching the disease earlier in patients. Mesothelioma is a hard-to-treat cancer mainly caused by asbestos. Once diagnosed, not much can be done because it has usually spread and progressed to a point where treatments like surgery, chemotherapy, and radiation[…]

Read More »

Researchers Possibly Found a MicroRNA Biomarker to Diagnose Mesothelioma

Italian researchers have potentially found a new biomarker for mesothelioma. The biomarker is a microRNA signature. This would allow doctors to determine if someone’s cancer is mesothelioma or another type of cancer quickly. Mesothelioma is a notoriously hard to treat cancer and early diagnosis is one of the keys to[…]

Read More »